PharmaResearch said it held a symposium to launch its new regenerative medical device, Rejuran, with its Chinese partner Yxintent, in Urumqi, Xinjiang Autonomous Region, on Wednesday last week.

At the symposium, Ok Seul-ong, a senior researcher at PharmaResearch, and Dr. Kim Soo-rim of TATOA China introduced the new product. With the launch, the company said that Rejuran would be introduced to the market of 17 regions in China, including Beijing, Shanghai, Zhejiang, Jiangsu, Sichuan provinces, and Xinjiang.

After signing an exclusive distribution agreement with its Chinese partner in January last year, PharmaResearch expands its wide networks by holding symposiums, seminars, and conferences.

“China is a very promising market for medical and beauty product makers,” a company official said. “We will continue marketing activities to promote Rejuran to a leading aesthetic product in the Chinese market.”